The Carlyle Group Makes Growth Investment in Pharmapacks
November 12, 2020
The Carlyle Group made a strategic growth investment of more than $250 million in Pharmapacks, an ecommerce marketplace enablement platform and large marketplace seller, valuing the company at approximately $1.1 billion. The capital is intended to accelerate Pharmapacks' growth by expanding fulfillment capacity, building out its data and analytics platform, and increasing the number of brand partners; J.P. Morgan served as lender and advisor on the transaction.
- Buyers
- The Carlyle Group
- Targets
- Pharmapacks
- Industry
- E-Commerce
- Location
- New York, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
The Carlyle Group Makes Majority Growth Investment in Every Man Jack
January 12, 2021
Consumer Products
Global investment firm The Carlyle Group agreed to make a majority growth investment in Every Man Jack, a founder-owned men's personal care brand focused on naturally derived ingredients. The capital will be used to accelerate the brand's growth—expanding e-commerce, optimizing supply chain, and broadening retail distribution across the U.S. and Canada.
-
The Carlyle Group Invests in MAK-SYSTEM
February 20, 2020
Healthcare Services
The Carlyle Group has made a significant investment in MAK-SYSTEM, a family-owned provider of blood management software, partnering with the Kiskovski family to accelerate the company’s growth. Carlyle’s equity commitment comes from Carlyle Europe Partners V and Carlyle Europe Technology Partners IV and will support product innovation and international expansion; Philippe Houssiau has been named CEO. Financial terms were not disclosed.
-
Carlyle and PayPal Invest $100M in Shopware
February 8, 2022
Cloud & SaaS
Shopware AG raised $100 million in growth capital from global investment firm Carlyle and payments platform PayPal to accelerate product innovation and international expansion. The Hamann founders retain a significant majority and will remain co-CEOs while Carlyle and PayPal provide capital and strategic support; Carlyle will also appoint board members.
-
The Carlyle Group Commits $374M Growth Investment in Amp Solar Group (Amp Energy)
January 6, 2021
Energy
The Carlyle Group committed $374 million through its Global Infrastructure Opportunity Fund and Renewable & Sustainable Energy Fund to Amp Solar Group, Inc. (Amp Energy), a Toronto-based global renewable energy developer, owner and operator. The growth capital will accelerate expansion of Amp's renewable asset base and its Amp X digital energy platform across core markets including North America, Japan, Australia, Iberia and the UK.
-
1315 Capital Backs USpharma Ltd. with Growth Equity Investment
June 30, 2025
Pharmaceuticals
USpharma Ltd., a Miami Lakes-based pharmaceutical development and manufacturing company, received a growth equity investment from Philadelphia-based 1315 Capital. The capital will be used to accelerate development and commercialization of USpharma’s pipeline, expand commercial reach, and scale operations at its 150,000 sq. ft. US-based GMP facility.
-
USPack (NewSpring Holdings) Acquires Capital Delivery Systems
January 8, 2021
Logistics & Distribution
USPack, a NewSpring Holdings platform company, acquired Capital Delivery Systems to expand its wholesale pharmaceutical and critical-parts distribution capabilities and extend final-mile coverage in the Mid-Atlantic and Northeast. The add-on bolsters USPack's healthcare logistics footprint and leverages its tech-enabled operating platform to provide greater visibility and expedited delivery for pharmaceutical and critical parts customers.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.